VF
IMUX icon

Virtu Financial’s Immunic IMUX Stock Holding History

Virtu Financial’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,337
Closed -$126K – 1904
2026
Q1 		$126K Buy
+11,337
New +$102K 0.01% 1138
2025
Q4 		– Sell
-11,229
Closed -$99K – 1922
2025
Q3 		$99K Buy
+11,229
New +$99K 0.01% 1045
2025
Q1 		– Sell
-1,213
Closed -$12K – 1669
2024
Q4 		$12K Sell
1,213
-1,823
-60% -$23K ﹤0.01% 1368
2024
Q3 		$50K Buy
+3,036
New +$43.2K ﹤0.01% 1013
2024
Q2 		– Sell
-1,909
Closed -$25K – 1569
2024
Q1 		$25K Buy
+1,909
New +$24.8K ﹤0.01% 1134
2023
Q3 		– Sell
-6,742
Closed -$169K – 1570
2023
Q2 		$169K Buy
+6,742
New +$113K 0.01% 862
2019
Q1 		– Sell
-776
Closed -$58K – 1616
2018
Q4 		$58K Buy
776
+424
+120% +$49.6K ﹤0.01% 1244
2018
Q3 		$39K Buy
+352
New +$919K ﹤0.01% 1334
2018
Q2 		– Sell
-43
Closed -$116K – 2229
2018
Q1 		$116K Buy
+43
New +$98.7K 0.01% 1543
2017
Q4 		– Sell
-53
Closed -$108K – 2645
2017
Q3 		$108K Buy
+53
New +$69.1K 0.01% 2054

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Virtu Financial's IMUX Position: Q2 2026 in Review

Virtu Financial sold out of Immunic (IMUX) in Q2 2026, closing a stake of 11,337 shares — an estimated $126K sold.

Virtu Financial first reported a position in IMUX in Q3 2017 and held it in 10 quarters. The position peaked at $169K in Q2 2023. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Virtu Financial reported no remaining Immunic position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 11,337 Immunic shares in Q2 2026, an estimated $126K.
  • Virtu Financial first reported a position in Immunic in Q3 2017 and held it in 10 quarters.
  • Virtu Financial's Immunic position peaked at $169K in Q2 2023.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.